Organigram Holdings Inc. (OGI)
After hours:
| Previous close | 1.8000 |
| Open | 1.8300 |
| Bid | 1.7500 x 400 |
| Ask | 1.7700 x 300 |
| Day's range | 1.7400 - 1.8300 |
| 52-week range | 0.9700 - 2.9100 |
| Volume | |
| Avg. volume | 1,570,796 |
| Market cap | 181.278M |
| Beta (5Y monthly) | 1.09 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.8300 |
| Earnings date | 14 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireOrganigram to Report Second Quarter Fiscal 2024 Results on May 14, 2024
TORONTO, May 08, 2024--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today it will report earnings results for its second quarter fiscal 2024 ended March 31, 2024, on Tuesday, May 14, 2024, prior to market open.
ZacksAre Medical Stocks Lagging OrganiGram (OGI) This Year?
Here is how OrganiGram (OGI) and ResMed (RMD) have performed compared to their sector so far this year.
Business WireOrganigram Recognized for Executive Gender Diversity by the Globe & Mail’s Women Lead Here Report for the Fourth Consecutive Year
TORONTO, April 08, 2024--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce it has been recognized on the 2024 Report on Business ‘Women Lead Here’ list for gender diversity. Fifty percent of the Company’s executive leadership team, including its CEO, are women.
